You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: February 28, 2024

Investigational Drug Information for AV-101

✉ Email this page to a colleague

« Back to Dashboard

What is the development status for investigational drug AV-101?

AV-101 is an investigational drug.

There have been 8 clinical trials for AV-101. The most recent clinical trial was a Phase 2 trial, which was initiated on November 2nd 2022.

The most common disease conditions in clinical trials are Depressive Disorder, Major, Pulmonary Arterial Hypertension, and Depressive Disorder. The leading clinical trial sponsors are VistaGen Therapeutics, Inc., Aerovate Therapeutics, and National Institute on Drug Abuse (NIDA).

There are twenty-four US patents protecting this investigational drug and two hundred and eighty-nine international patents.

Recent Clinical Trials for AV-101
Inhaled iMatinib Pulmonary Arterial Hypertension Clinical Trial - Follow Up Long Term Extension (IMPAHCT-FUL)Aerovate TherapeuticsPhase 2/Phase 3
AV-101 (L-4-chlorokynurenine) in Parkinson's Disease Subjects With Levodopa-Induced DyskinesiaVistaGen Therapeutics, Inc.Phase 2
AV-101 Alone and in Combination With Probenecid in Healthy SubjectsParexelPhase 1

See all AV-101 clinical trials

Clinical Trial Summary for AV-101

Top disease conditions for AV-101
Top clinical trial sponsors for AV-101

See all AV-101 clinical trials

US Patents for AV-101

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
AV-101 ⤷  Try a Trial Controlled release dosage form TRIASTEK, INC. (Nanjing, CN) ⤷  Try a Trial
AV-101 ⤷  Try a Trial Oral drug dosage forms having desired drug release profiles and uses thereof Triastek, Inc. (Nanjing, CN) ⤷  Try a Trial
AV-101 ⤷  Try a Trial Methods for the synthesis of chiral kynurenine compounds VISTAGEN THERAPEUTICS, INC. (South San Francisco, CA) ⤷  Try a Trial
AV-101 ⤷  Try a Trial Compartmented pharmaceutical dosage forms Triastek, Inc. (Nanjing, CN) ⤷  Try a Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for AV-101

Drugname Country Document Number Estimated Expiration Related US Patent
AV-101 Australia AU2017261372 2036-05-05 ⤷  Try a Trial
AV-101 Canada CA3023278 2036-05-05 ⤷  Try a Trial
AV-101 China CN107847398 2036-05-05 ⤷  Try a Trial
AV-101 European Patent Office EP3452003 2036-05-05 ⤷  Try a Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.